Lenalidomide overcomes the immunosuppression of regulatory CD8 + CD28 - T-cells

We analyzed in vitro the antigen-specific T-cell responses of healthy donors and patients with multiple myeloma with or without the addition of autologous CD8+CD28– T-cells in the absence and presence of lenalidomide. We found that lenalidomide enhances the antigen-specific secretion of IFN-γ and Gr...

Full description

Saved in:
Bibliographic Details
Main Authors: Neuber, Brigitte (Author) , Waraich, Wjahat Ahmed (Author) , Awwad, Mohamed (Author) , Engelhardt, Melanie (Author) , Schmitt, Michael (Author) , Witzens-Harig, Mathias (Author) , Ho, Anthony Dick (Author) , Goldschmidt, Hartmut (Author) , Hundemer, Michael (Author)
Format: Article (Journal)
Language:English
Published: October 05, 2017
In: OncoTarget
Year: 2017, Volume: 8, Issue: 58, Pages: 98200-98214
ISSN:1949-2553
DOI:10.18632/oncotarget.21516
Online Access:Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.18632/oncotarget.21516
Verlag, kostenfrei, Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=21516&path[]=68369
Get full text
Author Notes:Brigitte Neuber, Jingying Dai, Wjahat A. Waraich, Mohamed H. S. Awwad, Melanie Engelhardt, Michael Schmitt, Sergej Medenhoff, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt, Michael Hundemer, Brigitte Neuber, Jingying Dai, Wjahat A. Waraich, Mohamed H. S. Awwad, Melanie Engelhardt, Michael Schmitt, Sergej Medenhoff, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt and Michael Hundemer

MARC

LEADER 00000caa a2200000 c 4500
001 1581412711
003 DE-627
005 20220815022340.0
007 cr uuu---uuuuu
008 180928s2017 xx |||||o 00| ||eng c
024 7 |a 10.18632/oncotarget.21516  |2 doi 
035 |a (DE-627)1581412711 
035 |a (DE-576)511412711 
035 |a (DE-599)BSZ511412711 
035 |a (OCoLC)1341019331 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Neuber, Brigitte  |d 1974-  |e VerfasserIn  |0 (DE-588)1052913563  |0 (DE-627)789293188  |0 (DE-576)408653884  |4 aut 
245 1 0 |a Lenalidomide overcomes the immunosuppression of regulatory CD8 + CD28 - T-cells  |c Brigitte Neuber, Jingying Dai, Wjahat A. Waraich, Mohamed H. S. Awwad, Melanie Engelhardt, Michael Schmitt, Sergej Medenhoff, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt, Michael Hundemer, Brigitte Neuber, Jingying Dai, Wjahat A. Waraich, Mohamed H. S. Awwad, Melanie Engelhardt, Michael Schmitt, Sergej Medenhoff, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt and Michael Hundemer 
264 1 |c October 05, 2017 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.09.2018 
520 |a We analyzed in vitro the antigen-specific T-cell responses of healthy donors and patients with multiple myeloma with or without the addition of autologous CD8+CD28– T-cells in the absence and presence of lenalidomide. We found that lenalidomide enhances the antigen-specific secretion of IFN-γ and Granzyme B despite the addition of CD8+CD28– T-cells. Furthermore, we showed that lenalidomide inhibits the IL-6 secretion of mononuclear cells, triggered by CD8+CD28– T-cells. 
700 1 |a Waraich, Wjahat Ahmed  |d 1987-  |e VerfasserIn  |0 (DE-588)1160452016  |0 (DE-627)1023625261  |0 (DE-576)505898624  |4 aut 
700 1 |a Awwad, Mohamed  |d 1991-  |e VerfasserIn  |0 (DE-588)1168051754  |0 (DE-627)1031749411  |0 (DE-576)511411774  |4 aut 
700 1 |a Engelhardt, Melanie  |d 1980-  |e VerfasserIn  |0 (DE-588)1045014486  |0 (DE-627)773400761  |0 (DE-576)398327106  |4 aut 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
700 1 |a Witzens-Harig, Mathias  |e VerfasserIn  |0 (DE-588)1050736516  |0 (DE-627)784812322  |0 (DE-576)404988970  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Hundemer, Michael  |d 1972-  |e VerfasserIn  |0 (DE-588)128390549  |0 (DE-627)372634001  |0 (DE-576)297117998  |4 aut 
773 0 8 |i Enthalten in  |t OncoTarget  |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010  |g 8(2017), 58, Seite 98200-98214  |h Online-Ressource  |w (DE-627)63035975X  |w (DE-600)2560162-3  |w (DE-576)325343764  |x 1949-2553  |7 nnas  |a Lenalidomide overcomes the immunosuppression of regulatory CD8 + CD28 - T-cells 
773 1 8 |g volume:8  |g year:2017  |g number:58  |g pages:98200-98214  |g extent:15  |a Lenalidomide overcomes the immunosuppression of regulatory CD8 + CD28 - T-cells 
856 4 0 |u http://dx.doi.org/10.18632/oncotarget.21516  |x Resolving-System  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=21516&path[]=68369  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180928 
993 |a Article 
994 |a 2017 
998 |g 128390549  |a Hundemer, Michael  |m 128390549:Hundemer, Michael  |d 910000  |d 910100  |e 910000PH128390549  |e 910100PH128390549  |k 0/910000/  |k 1/910000/910100/  |p 11  |y j 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 1050736516  |a Witzens-Harig, Mathias  |m 1050736516:Witzens-Harig, Mathias  |d 910000  |d 910100  |e 910000PW1050736516  |e 910100PW1050736516  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1045014486  |a Engelhardt, Melanie  |m 1045014486:Engelhardt, Melanie  |d 910000  |d 910100  |e 910000PE1045014486  |e 910100PE1045014486  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1168051754  |a Awwad, Mohamed  |m 1168051754:Awwad, Mohamed  |d 910000  |d 910100  |e 910000PA1168051754  |e 910100PA1168051754  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1160452016  |a Waraich, Wjahat Ahmed  |m 1160452016:Waraich, Wjahat Ahmed  |d 910000  |d 910100  |e 910000PW1160452016  |e 910100PW1160452016  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1052913563  |a Neuber, Brigitte  |m 1052913563:Neuber, Brigitte  |d 910000  |d 910100  |e 910000PN1052913563  |e 910100PN1052913563  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1581412711  |e 3027411888 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1581412711","origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"October 05, 2017"}],"name":{"displayForm":["Brigitte Neuber, Jingying Dai, Wjahat A. Waraich, Mohamed H. S. Awwad, Melanie Engelhardt, Michael Schmitt, Sergej Medenhoff, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt, Michael Hundemer, Brigitte Neuber, Jingying Dai, Wjahat A. Waraich, Mohamed H. S. Awwad, Melanie Engelhardt, Michael Schmitt, Sergej Medenhoff, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt and Michael Hundemer"]},"person":[{"given":"Brigitte","display":"Neuber, Brigitte","family":"Neuber","role":"aut"},{"role":"aut","display":"Waraich, Wjahat Ahmed","given":"Wjahat Ahmed","family":"Waraich"},{"role":"aut","given":"Mohamed","display":"Awwad, Mohamed","family":"Awwad"},{"family":"Engelhardt","given":"Melanie","display":"Engelhardt, Melanie","role":"aut"},{"display":"Schmitt, Michael","given":"Michael","family":"Schmitt","role":"aut"},{"role":"aut","given":"Mathias","display":"Witzens-Harig, Mathias","family":"Witzens-Harig"},{"display":"Ho, Anthony Dick","given":"Anthony Dick","family":"Ho","role":"aut"},{"role":"aut","family":"Goldschmidt","display":"Goldschmidt, Hartmut","given":"Hartmut"},{"role":"aut","family":"Hundemer","given":"Michael","display":"Hundemer, Michael"}],"language":["eng"],"title":[{"title":"Lenalidomide overcomes the immunosuppression of regulatory CD8 + CD28 - T-cells","title_sort":"Lenalidomide overcomes the immunosuppression of regulatory CD8 + CD28 - T-cells"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1581412711"],"doi":["10.18632/oncotarget.21516"]},"physDesc":[{"extent":"15 S."}],"relHost":[{"language":["eng"],"disp":"Lenalidomide overcomes the immunosuppression of regulatory CD8 + CD28 - T-cellsOncoTarget","recId":"63035975X","pubHistory":["1.2010,Mai -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"OncoTarget","title_sort":"OncoTarget","subtitle":"open access impact journal"}],"origin":[{"dateIssuedDisp":"2010-","publisher":"Impact Journals LLC","publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedKey":"2010"}],"note":["Gesehen am 16.08.2018"],"id":{"eki":["63035975X"],"issn":["1949-2553"],"zdb":["2560162-3"]},"part":{"text":"8(2017), 58, Seite 98200-98214","volume":"8","pages":"98200-98214","year":"2017","issue":"58","extent":"15"},"physDesc":[{"extent":"Online-Ressource"}]}],"note":["Gesehen am 28.09.2018"]} 
SRT |a NEUBERBRIGLENALIDOMI0520